Steven Cohen's LAB Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 707,991 shares of Standard BioTools Inc. (LAB) worth $582,464, representing 0.00% of the portfolio. First purchased in 2015-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in LAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 663,270 shares. Largest reduction occurred in Q3 2020, reducing 399,415 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Standard BioTools (LAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Standard BioTools (LAB) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +663,270 | Add 1483.13% | 707,991 | $0.82 |
| Q1 2026 | -98,586 | Reduce 68.79% | 44,721 | $0.92 |
| Q4 2025 | +143,307 | New Buy | 143,307 | $1.28 |
| Q2 2024 | -142,300 | Sold Out | 0 | $0.00 |
| Q1 2024 | +142,300 | New Buy | 142,300 | $2.71 |
| Q4 2023 | -34,582 | Sold Out | 0 | $0.00 |
| Q3 2023 | +34,582 | New Buy | 34,582 | $2.90 |
| Q3 2020 | -399,415 | Sold Out | 0 | $0.00 |
| Q2 2020 | +399,415 | New Buy | 399,415 | $4.01 |
| Q3 2015 | -63,400 | Sold Out | 0 | $0.00 |
| Q2 2015 | +63,400 | New Buy | 63,400 | $24.20 |
Steven Cohen's Standard BioTools Investment FAQs
Steven Cohen first purchased Standard BioTools Inc. (LAB) in Q2 2015, acquiring 63,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Standard BioTools Inc. (LAB) for 11 quarters since Q2 2015.
Steven Cohen's largest addition to Standard BioTools Inc. (LAB) was in Q2 2026, adding 707,991 shares worth $582,464.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 707,991 shares of Standard BioTools Inc. (LAB), valued at approximately $582,464.
As of the Q2 2026 filing, Standard BioTools Inc. (LAB) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Standard BioTools Inc. (LAB) was 707,991 shares, as reported at the end of Q2 2026.